Iron overload without the C282Y mutation in patients with epilepsy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 4, 2001, Pages 551-553

  Ikeda, M ^a  

^a National Saigata Medical Center   (Japan)

Author keywords

Epilepsy; Haemochromatosis; Iron overload

Indexed keywords

CARBAMAZEPINE; FERRITIN; IRON; PHENOBARBITAL; PHENYTOIN; TRANSFERRIN; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HUMAN; IRON KINETICS; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE SUSCEPTIBILITY;

ADULT; EPILEPSY; FEMALE; HEMOCHROMATOSIS; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; MUTATION; TRANSFERRIN;

EID: 0035060182     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.4.551     Document Type: Article

References (20)

1. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-23.
2. Berg D, Hoggenmuller U, Hofmann E, et al. The basal ganglia in haemochromatosis. Neuroradiology 2000;42:9-13.
3. Cutler P. Iron overload and psychiatric illness. Can J Psychiatry 1994;39:8-11.
4. Milder MS, Cook JD, Stray S, et al. Idiopathic hemochromatosis, an interim report. Medicine 1980;59:34-49
5. Nielsen JE, Jensen LN, Krabbe K. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J Neurol Neurosurg Psychiatry 1995;59:318-21.
6. Miyasaki K, Murao S, Koizumi N. Hemochromatosis associated with brain lesions: a disorder of trace-metal binding proteins and/or polymers? J Neuropathol Exp Neurol 1977;36:964-76.
7. Jones HJ, Hedley WE. Idiopathic hemochromatosis (IHC): dementia and ataxia as presenting signs. Neurology 1983;33:1479-83.
8. Hughes JT, Oppenheimer DR. Superficial siderosis of the central nervous system. A report on nine cases with autopsy. Acta Neuropathol (Berl) 1969;13:56-74.
9. Rojas G, Messen L. Generalized cytosiderosis in two cases of progressive myoclonic epilepsy with Lafora inclusion bodies. Histopathological and ultrastructural studies. Neurocirugia 1968;26:3-11.
10. Campbell KA, Bank B, Milgram NW. Epileptogenic effects of electrolytic lesions in the hippocampus: role of iron deposition. Exp Neurol 1984;86:506-14.
11. 3 injection into rat isocortex. Brain Res 1983;277:393-6.
12. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
13. Beutler E, Gelbart T. Large-scale screening for HFE mutations: methodology and cost. Genet Test 2000;4:131-12.
14. Garzon P, Garcia LP, Garcia EJ, et al. Iron binding to nutrients containing fiber and phenytoin. Gen Pharmacol 1986; 17:661-4.
15. Critchfield JW, Carl FG, Keen CL. Anticonvulsant-induced changes in tissue manganese, zinc, copper, and iron concentrations in Wistar rats. Metabolism 1993;42: 907-10.
16. Pick CG, Statter M, Ben SD, et al. Normal zinc and iron concentrations in mice after early exposure to phenobarbital. Int J Dev Neurosci 1987;5:391-8.
17. Witte DL, Crosby WH, Edwards CQ, et al. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
18. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
19. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998;280:172-8.
20. Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. Am J Hum Genet 1997;61:762-4.